RVNC

Revance Therapeutics, Inc.
RVNC

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

66 hedge funds and large institutions have $373M invested in Revance Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$145M
2
+$28.3M
3
+$16.7M
4
CWAM
Columbia Wanger Asset Management
Illinois
+$16.4M
5
Millennium Management
Millennium Management
New York
+$10.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$145M
2
$28.3M
3
$16.7M
4
$16.4M
5
$10.1M
6
$10.1M
7
$9.95M
8
$9.55M
9
$9.45M
10
$9.12M
11
$8.48M
12
$8.46M
13
$7.79M
14
$7.66M
15
$5.98M
16
$5.51M
17
$5.18M
18
$4.78M
19
$4.25M
20
$3.9M
21
$3.68M
22
$3.15M
23
$3.15M
24
$2.89M
25
$2.89M
1
2 3